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-related distress in states of type 2 diabetes 
in the first multi-national Diabetes Attitudes, 
Wishes and Needs (DAWN) Study
ABSTRACT
Purpose. To examine well-being and diabetes-related 
distress across several common states differentiated 
in the course of type 2 diabetes. 
Material and methods. Random samples of adults 
with type 2 diabetes were obtained from multiple co-
untries in the first DAWN (Diabetes Attitudes, Wishes, 
and Needs) Study (n = 3432). All data were obtained 
during structured interviews. Criteria for defining 
states of diabetes included time since diagnosis of 
diabetes, the timing and nature of anti-hyperglycaemic 
medication regimens, and the timing and number of 
complications. 
Results. Duration of diabetes closely corresponded 
to a set of typical states based on the criteria. Using 
analysis of covariance to control for confounding 
factors, diabetes-related distress and psychological 
well-being were significantly (p < 0.05) worse for 
persons with diabetes with more complications and 
more intense medication regimens. Longer duration 
of insulin use was significantly associated with more 
diabetes-related distress. Worse distress and well-being 
were significantly associated with the accumulation 
of complications over time, but were more strongly 
associated with recently diagnosed complications than 
with more distally diagnosed complications.
Conclusions. Well-being and distress varied over sta-
tes as defined by the nature and timing of diagnoses 
and medications. The observed patterns were more 
complex than a linear model of disease staging would 
suggest. (Clin Diabetol 2019; 8, 3: 167–175)
Key words: psychological well-being, diabetes, type 2 
diabetes, diseases states, diagnosis, complications, 
treatment regimen
Introduction
It is well-recognized that type 2 diabetes is 
a progressive disease [1]. It has been proposed that 
diabetes can be conceptualized in terms of stages, but 
differentiation of its stages is less clear than in other 
life-long illness. Stages of overt type 2 diabetes have 
been identified based on the need for insulin, including 
not insulin requiring and requiring insulin for control [2, 
3]. Similar staging was accepted by the Japan Diabetes 
Society [4]. Disease staging by Gonnella [5] included 
complications as a criterion. Because the course of type 
2 diabetes may not follow consecutively all described 
states, our notion of “states” occurring over the course 
of diabetes de-emphasizes the requirement that there 
be a fixed order of progression across the states. The 
majority of cases can be classified into several states 
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according to concrete criteria reflecting the progression 
of diabetes, including duration of diabetes diagnosis, 
therapeutic regimen — lifestyle intervention, oral anti-
hyperglycemic medications (OAM), and injections — 
and occurrence of complications. 
What is less clear is how the progression of diabetes 
disease severity manifests itself in the psychological 
life of people with diabetes — how do the states in 
the progression of diabetes affect their psychological 
adjustment to having diabetes? The early work on 
this topic conceptualized the progression in terms of 
the predictable crises of diabetes [6], starting with the 
diagnosis of diabetes through changes in the intensity 
of medication regimens necessary to control blood 
glucose levels, and the onset of diabetic complications, 
hospitalization and the threat of imminent death. This 
work suggested that these events are associated with 
changes in psychological adjustment, with the implica-
tion that for each event there is a crisis period followed 
by a period of accommodation. 
In this paper we seek to develop a multi-dimen-
sional typology of the states in the course of type 2 
diabetes and examine the impact of these states on 
two indicators of psychological adjustment in people 
with diabetes — psychological well-being and diabetes-
related distress.
Our typology is based on two criteria that define 
the different states. The first criterion is the type of 
event. We identify three such events:
 — diagnosis of diabetes;
 — major intensification of glucose lowering treat-
ment (first oral medication, first injected medica-
tion);
 — diagnosis of a diabetic complication. 
The second criterion is the recency/latency of 
a criterion event (diagnosis or major treatment inten-
sification). For the purpose of this paper we define 
a recent event as one that has occurred within the last 
year, while events having occurred more than a year 
ago are not recent.
There is evidence to support an association of 
psychological adjustment with each of the criteria 
noted above. Having type 2 diabetes is associated with 
higher levels of depression [7], and type 2 diabetes is 
associated with greater severity of depressive symptoms 
among those newly diagnosed than those previously 
diag nosed [8]. Among people with type 2 diabetes 
those treated with insulin have higher levels of depres-
sion than those not using insulin [9, 10], although 
insulin initiation may be associated with a short-term 
reduction in depression [11, 12]. Complications are 
associated with greater depression or diabetes-related 
distress [7, 13–16], with some evidence that depression 
rises at onset and resolves over time [17, 18]. 
Another formal property of our typology is the na-
ture of progression across states: 1) Mechanical models 
define the progression as entirely predictable; the next 
state to be occupied is entirely determined by the cur-
rent state, with no reversal in the progression, no skip-
ping of states, etc. 2) Probabilistic models regard the 
progression as only partially predictable; state reversal 
and skipping may occur. Hybrid typologies, like the one 
proposed here, are a combination of the two models. 
Treatment intensification involves probabilistic pro-
gression; the exact progression is not predetermined, 
but given a current level of treatment intensity some 
next states are more likely than others. Complications 
involves a mechanist progression; a person with diabe-
tes must have one complication before they have two 
complications, and for the most part complications do 
not reverse themselves (although they may be success-
fully treated). Recency/latency involves a mechanistic 
progression in that an event must have been recent 
before it becomes non-recent, and a non-recent event 
cannot become recent (although additional events may 
occur, thereby adding another recent event to existing 
events, e.g., new complications).
The criteria defined above were used to generate 
a set of nine states representing a typical progression 
of diabetes (“typical” in that actual progression of any 
given patient may not follow the progression hypo-
thesized here). In addition to the logical requirements 
of mechanical progression, we make two probabilistic 
assumptions based on empirical considerations: 
 — for treatment intensification no medication pre-
cedes oral medication, and oral medication pre-
cedes insulin; 
 — for the relationship between treatment intensi-
fication and complications insulin initiation pre-
cedes complications. 
Thus, the resulting typical diabetes states (in order 
from earliest to latest) are: 
 — new diagnosis of diabetes, no medication, no 
complications; 
 — old diagnosis of diabetes, no medication, no 
complications; 
 — old diagnosis of diabetes, oral medication, no 
complications; 
 — old diagnosis of diabetes, recent initiation of in-
sulin, no complications; 
 — old diagnosis of diabetes, old initiation of insulin, 
no complications; 
 — old diagnosis of diabetes, old initiation of insulin, 
recent complication only; 
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 — old diagnosis of diabetes, old initiation of insulin, 
one old complication; 
 — old diagnosis of diabetes, old initiation of insulin, 
one old complication and one recent complica-
tion; 
 — old diagnosis of diabetes, old initiation of insulin, 
two old complications. 
Additional states beyond the last one could be 
postulated but they would involve the replication of 
the pattern represented by the last several states — 
onset of a third complication and its transition to an 
old complication, followed by a fourth cycle of com-
plications, etc. For the purpose of simplification, and 
given the difficult of obtaining a sample large enough 
and with a high enough level of complications to be 
able to examine additional states, we limit ourselves 
to these nine states. 
Using the proposed multi-dimensional typology of 
disease states, we assess: 
 — the impact of our criteria on the psychological ad-
justment of people with diabetes;
 — the degree to which the order of the states corre-
sponds to the actual duration of diabetes for the 
people with diabetes occupying those states (i.e., 
represent a progression);
 — the degree to which these states of diabetes cap-
ture variation in the indicators of psychological 
adjustment.
Material and methods
Study background
The study design of the first Diabetes Attitudes, 
Wishes and Needs (DAWN) Study, described in detail 
elsewhere [19, 20], was a cross-sectional survey. In 2001 
telephone or face-to-face interviews (in respondents’ 
native language) were conducted in 13 countries rep-
resenting 11 regions in Asia, Australia, Europe, and 
North America. There were three independent surveys 
of random samples of respondents: 5,426 adults who 
self-identified as having diabetes (~500 per region), 
2,750 physicians (~200 primary care physicians and 
~50 diabetes specialists per region), and 1,122 nurses 
(~50 diabetes specialists and 50 generalists per region). 
The study was conducted according to the Joint 
Guidelines on Pharmaceutical Research Practice of the 
British Healthcare Business Intelligence Alliance and 
the Association of the British Pharmaceutical Indus-
try. Verbal informed consent was obtained from all 
respondents and participation was voluntary. Ethical 
approval of the study protocol and use of these data 
was obtained from the institutional review board at 
Loyola University Maryland (the Human Subjects Re-
search Committee).
Study subjects
Inclusion criteria were age 18–80 and self-identified 
as diagnosed with diabetes for at least six months. 
Exclusion criteria were severe physical or mental ill-
ness. The selection quota was for approximately equal 
numbers of people with self-reported type 1 and type 2 
diabetes mellitus. This paper uses data from all people 
with diabetes who could be classified as having type 2 
diabetes mellitus according to the following criteria: 
diagnosed at or after age 40, and not treated with 
insulin both at diagnosis and at the time of the survey.
Measures
Respondent demographics
In addition to country of residence, respondent 
demographic characteristics included sex, age, marital 
status (married or not), and residential urbanicity (rural, 
suburban, small urban, large urban).
Diabetes states
There were three main criteria for defining disease 
states: 
 — time since diagnosis of diabetes (up to one year 
vs. more than one year);
 — glucose control medication regimen (none, oral 
only, insulin and oral, insulin only); 
 — pattern of complications (absence/presence of 
complications with onset of more/less than one 
year).
There were two secondary criteria: time since in-
sulin initiation (up to one year vs. more than one year) 
and number of complications. The number of compli-
cations was a count of conditions reported as being 
under treatment from a list including 15 possibilities.
Psychological outcomes
Well-being was assessed by the WHO-5 measure 
[21] (alpha = 0.83). It has adequate validity both as 
a screening tool for depression and as an outcome meas-
ure in clinical trials [20]. The raw score is calculated by 
totaling the figures of the five answers. The raw score 
ranges from 0 to 25, 0 representing worst possible and 
25 representing best possible quality of life. To obtain 
a percentage score ranging from 0 to 100, the raw score 
is multiplied by 4. A percentage score of 0 represents 
worst possible, whereas a score of 100 represents best 
possible well-being. Diabetes-related distress was as-
sessed with a multi-item scale developed for this study 
and using the following seven items (alpha = 0.79): 
being stressed about diabetes, burned out from coping 
with diabetes, tired of complying with medications, 
afraid diabetes is getting worse, diabetes-related worry 
about family responsibilities, diabetes-related worry 
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about financial future, worry about hypoglycemia. 
Response options (Fully disagree = 0, Mainly disagree 
= 1, Mainly agree = 2, Fully agree = 3) were multiplied 
by 100/3 and the score was calculated as the mean of 
completed items. Scores could range from 0 to 100. 
Statistical analysis
The main analyses of well-being and diabetes-
-related distress used analysis of covariance (ANCOVA) 
and controlled for all respondent characteristics listed 
in Table 1 (country, residential urbanicity, age, gender, 
marital status). 
A single multivariate model was estimated to iden-
tify independent (additive) relationships of diabetes-
related distress and psychological well-being with each 
of the three state-defining criteria (duration of diabetes 
diagnosis, type and duration of medication use, and 
duration/number of complications). Several ancillary 
analyses were conducted using multiple regression. 
Two of these analyses examined whether each of the 
secondary criteria (duration of insulin use and number 
of complications) were related to the study outcomes. 
Two other ancillary analyses examined whether there 
was (a) a nonlinear relationship between number of 
complications and study outcomes, and (b) an interac-
tion between number of complications and presence 
of a new complication.
Effect parameters (unstandardized coefficients) 
from multiple regression equations were used to es-
timate distress and well-being for each of nine states 
defined by combinations of the three criteria. Then 
these estimated levels of psychological adjustment 
were compared with actual levels of psychological 
adjustment for those classified into the states. To 
validate the temporal ordering of the typical diabetes 
states the mean duration of diabetes for people with 
diabetes in those states was examined; the hypothesis is 
a monotonic increase in duration across the nine states. 
Results
Sample profile
The final sample consisted of 3432 adults with 
type 2 diabetes mellitus (see Table 1). Slightly over half 
(54%) were female, with a median age of 59, and most 
(72%) were married. Country samples ranged from 
247 to 386, and respondents were mostly from urban 
locales (57%) [23].
Most respondents (93%) had been diagnosed with 
diabetes over a year (mean duration of 11 years). Only 
12% did not take medication to control blood glucose, 
and 40% took insulin (5% had started insulin in the last 
year). A third of respondents (29%) had one or more 
diabetes complications, with 13% having new compli-
cations (less than 1 year duration) and 22% had com-
plications of longer duration. The maximum number 
of complications was 4, with mean of less than a third 
of a complication per respondent; the modest level of 
complications reflects the fact that respondents have 
a mean age of only 59 and a mean diabetes duration 
of only 11 years.
Outcomes by state criteria
Results are reported in Table 2. Neither well-being 
nor diabetes-related distress was significantly associ-
Table 1. Sample profile
Measures % (N) or M + SD
Country
Australia 9.2 (317)
France 7.3 (249)
Germany 8.7 (299)
India 8.7 (299)
Japan 10.8 (370)
Netherlands 10.0 (344)
Poland 7.2 (247)
Scandinavia 8.7 (300)
Spain 7.7 (264)
United States 11.2 (386)
United Kingdom 10.4 (357)
Female 54.2 (1861)
Married 72.1 (2473)
Residential urbanicity
Rural 22.5 (772)
Suburban 20.5 (705)
Small urban 18.2 (626)
Large urban 38.3 (1316)
Age (years) 59.28 ± 11.84
Diabetes diagnosed in last year 6.8 (232)
Duration of diabetes 11.22 ± 9.49
Medications
None 12.4 (425)
Oral medications only 47.7 (1636)
Insulin 39.9 (1371)
Start insulin in last year 4.5 (155)
Complications
None 71.2 (2444)
New complications only 6.7 (229)
Old complications only 16.0 (549)
New and old complications 6.1 (210)
Number of complications 0.29 ± 0.63
WHO-5 well-being 54.90 ± 23.54
Diabetes-related distress 33.74 ± 22.95
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ated with diagnosis of diabetes within the last year 
(given the exclusion criteria, this actually refers to diag-
nosis between 6 and 12 months ago). However, because 
the direction of association was in opposite directions 
for the two outcomes we conducted an additional 
analysis. We first reverse scored well-being so that it 
was an indicator of general psychological distress, then 
we performed a MANOVA to assess whether there was 
an interaction between time of diagnosis (new versus 
old diagnosis of diabetes) and type of distress (general 
versus diabetes-related). The result was a statistically 
significant interaction (p = 0.008), with less general 
distress and more diabetes-related distress among 
those with a recent diagnosis of diabetes.
Well-being and diabetes-related distress were 
associated with the intensity of the glucose lowering 
medication regimen at different levels (p = 0.061 and 
p < 0.001, respectively). The level of well-being was 
lowest among those taking insulin only and highest 
among those taking oral medications only, with those 
taking no medication or both insulin and oral medica-
tions intermediate; only the two groups with the most 
extreme values were significantly different. Diabetes-
related distress in those taking insulin was significantly 
higher than the group taking only oral medication, 
which was significantly higher than among those not 
taking glucose lowering medication.
Well-being and diabetes-related distress both 
differed significantly (p < 0.001) across complication 
subgroups. Well-being was highest among those with 
no complications and significantly lower among those 
with only complications of more than a year’s duration; 
those with a complication of recent onset (less than 
12 months ago), with or without complications of 
longer duration, were significantly lower than the other 
groups. Diabetes-related distress followed a similar 
pattern — lowest among those with no complications 
and significantly higher among those with only com-
plications of more than a year’s duration; those with 
complication of recent onset (less than 12 months ago), 
with or without complications of longer duration, were 
significantly higher than the other groups. 
Although our primary ANCOVA assumed only ad-
ditive relationships we conducted additional ANCOVA 
to determine whether there were interactions (two-
way or three-way) among the three main criteria. For 
well-being there were no significant interactions. For 
diabetes-related distress there was one significant 
(p = 0.005) interaction, between duration of diabetes 
and type of complications; new complications were 
associated with a greater elevation in distress among 
those with recently diagnosed diabetes. 
Another ancillary analysis examined whether num-
ber of complications of over a year’s duration (“old” 
complications) was a more powerful predictor of well-
being and distress than merely the absence/presence 
of such complications. While the effect of a single 
old complication was much less than that of a new 
complication, the effect of two, or three, old complica-
tions was greater than that of a new complication (for 
well-being and diabetes-related distress, respectively). 
Another ancillary analysis demonstrated that the re-
lationship of psychological adjustment with number 
of complications was linear rather than nonlinear. We 
also examined whether there was a significant inter-
action between number of old complications and the 
presence of a new complication; for diabetes-related 
distress the interaction was significant (p = 0.002) as 
the number of old complications had a much stronger 
impact among those with no new complication (effect 
Table 2. Least square means of well-being and diabetes-related distress for disease state markers
Disease state markers WHO-5 well-being Diabetes-related distress
Mean Std. error Mean Std. error
DM Dx < 1 year past 53.19a 1.62 40.08a 1.52
DM Dx > 1 year past 50.50a 0.68 38.44a 0.64
No medication 52.07a, b 1.39 33.89a 1.31
Oral medication only 52.74b 1.01 40.39b 0.95
Insulin 50.71a 1.06 43.49c 0.99
No complications 58.15c 0.83 29.75a 0.77
New complications only 48.26a 1.65 45.30c 1.55
Old complications only 53.14b 1.23 36.56b 1.16
Old and new complications 47.80a 1.76 45.42c 1.66
Note: Least Square means adjusted for country, age, sex, marital status, residential urbanicity, and all diabetes state markers. Means with the same super-
script are not significantly different (p > 0.05); means without the same superscript are significantly different [p < 0.005 except insulin vs. oral medication 
only for well-being (p = 0.018) and new complications only vs. old complications only for well-being (p = 0.006)]
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parameter = 5.63, p > 0.001) than among those with 
a new complication (effect parameter = 2.22, p = ns). 
Assessment of typical states of diabetes
Table 3 shows that the 2701 of the 3432 partici-
pants (79%) fell into one of the nine typical states (80% 
of those with two or less complications). 
Over half of those not falling into one of the 
typical states were people who had complications but 
had not yet started insulin therapy. The hypothesized 
temporal ordering of the typical diabetes states exactly 
corresponds to the actual ordering of the states as 
measured by the mean duration of diabetes for those 
in each state. Similarly, the estimated levels of well-
being and diabetes-related distress based on the model 
parameters correspond closely to the actual levels, 
especially in the intermediate states which represent 
the majority of the data used to generate the estimated 
effect parameters. 
Discussion
The findings of this study indicate that both 
psychological wellbeing and diabetes-related distress 
have similar significant independent relationships with 
several components of our multi-dimensional typology, 
including the timing (recency/latency) of events, the 
level of treatment intensity, and the number of com-
plications. Moreover, the ordered set of typical states 
represented by a combination of these components 
seems to correspond closely to the actual occurrence 
of these states in the study sample, as indicated by the 
duration of diabetes for people occupying those states.
There was evidence to support the three-level 
categorization of treatment intensity, with each level 
being significantly different from another level for at 
least one indicator of psychological adjustment. Greater 
treatment intensity generally was associated with worse 
psychological adjustment, although those taking oral 
medication had slightly (i.e., not significantly) higher 
well-being than those not taking glucose-lowering 
medication. 
Number of complications had the strongest rela-
tionship with psychological adjustment. Each additional 
complication was associated with a decrement in psycho-
logical adjustment about twice the size of the decrement 
associated with insulin treatment. This finding is consist-
ent with previous research indicating that complications 
are associated with declines in psychological adjustment. 
However, recent research suggests that this relationship 
may be bi-directional, with depression increasing the risk 
of complications [24, 25] as well as the reverse [24, 26]. 
There is also evidence to suggest that the association 
between psychological adjustment and the state-defining 
events (change in treatment and occurrence of complica-
tions) is dependent on the timing of the events. Although 
time since diabetes diagnosis was not significant in the 
multivariate analyses based on all patients, there were 
substantial decrements in both indicators of psychologi-
cal adjustment for those with longer time since diagnosis 
when the comparison was limited to those with no other 
risk factors (no medication and no complications). There 
was a similar relationship with time since initiation of 
insulin treatment; this was significant in multivariate 
analyses that controlled for occurrence of complications. 
Conversely, psychological adjustment was better for those 
whose complications were further in the past. Thus, the 
timing of events does not have a universal association with 
psychological adjustment; sometimes less recent events 
have a stronger association than more recent events, and 
sometimes vice-versa.
The temporal ordering of the typical states identi-
fied here was validated by the duration of diabetes 
Table 3. Duration of diabetes, well-being, and diabetes-related distress for typical states of diabetes
DM diagnosis Medications Complications N DM duration Well-being Distress
New None None 55 0.9 59 (64) 29
Old None None 314 7.7 57 24
Old Oral only None 1107 8.8 58 30
Old New insulin None 80 12.2 56 29
Old Old insulin None 745 14.9 57 32
Old Old insulin New only 105 17.4 46 (48) 48
Old Old insulin One old only 183 18.1 54 (52) 38
Old Old insulin One old and new 73 18.7 49 (47) 49
Old Old insulin Two old only 39 20.5 40 48
Note: Values for N and duration are actual values for those who fall into the groups representing each state. Values for well-being and distress are least 
square means obtained from regression models including diagnosis, medications, and complications. Where the actual mean for the group differs from 
the least square mean by more than 1 point, the actual group mean is shown in parentheses. New diagnosis, new insulin and new complications represent 
events taking place within one year prior to the study
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associated with being in those states; the actual du-
ration was entirely consistent with the hypothesized 
temporal ordering. When comparing estimated and 
actual levels of psychological adjustment the differ-
ences between them were mostly at the extremes 
and for smaller groups of people with diabetes. Since 
there were relatively few participants in these groups 
we must be cautious in making conclusions regarding 
these groups and the effects giving rise to differences 
among these groups. This is especially true for two sets 
of findings. For the comparison of states one and two 
the actual well-being scores of those with more time 
since diabetes diagnosis show a greater worsening than 
estimated scores; moreover, these states exhibit one of 
the few inconsistencies between the findings for well-
being and distress, as the latter shows a substantial 
improvement for the same group. The second finding 
to view with caution is the finding regarding well-being 
for the onset and duration of a second complication. 
The estimated data necessarily shows the pattern to 
be the same for the initial and second complications 
(well-being improves as the complication recedes in 
time); for the actual data this pattern is replicated for 
the first complication, but for the second complica-
tion well-being worsens with time since the event. 
The pattern for actual diabetes-related distress scores 
is consistent with the pattern for estimated well-being 
scores; adjustment improves as the second complica-
tion recedes in time. 
A final comment about the multivariate analyses; 
they demonstrate few non-additive or non-linear rela-
tionships. Number of complications did not exhibit a 
non-linear relationship with well-being or distress. Of 
the eight two-way or three-way interactions among the 
three main criteria for the two outcomes, only one was 
significant. Perhaps the most interesting departure from 
simple additive effects is the interaction between having 
a new complication and number of complications for 
diabetes-related distress. For patients with recent onset 
of a complication the number of existing complications 
is not associated with an increase in distress; this is 
confirmed by the equal levels of actual distress for those 
with only a new complication and those with a new 
complication as well as one old complication.
Study strengths and limitations
The major strength of this study is the availability 
of a large sample with a diverse population which al-
lows us to compare people with diabetes with various 
combinations of the characteristics defining the typical 
states of diabetes. The fundamental limitation of this 
paper is the cross-sectional nature of the data used to 
evaluate the proposed multi-dimensional typology of 
diabetes states. Ideally, we would be able to follow 
people with diabetes over time to see whether they ex-
perience events in the order our typology hypothesizes, 
and prospectively observe changes in psychological 
adjustment associated with the transition from one 
state to another. Absent longitudinal data, our results 
are suggestive rather than definitive (although this is 
the first large study to comprehensively examine this 
issue). Another limitation is that we do not have enough 
people with diabetes in some states to be able to ob-
tain reliable estimates of the differences among states; 
this is particularly true for assessment of the impact 
of newly diagnosed diabetes and recent initiation of 
insulin (or oral medication) therapy (fortunately, other 
studies provide evidence regarding the impact of these 
events on psychological adjustment). In addition, this 
study used a newly developed measure of diabetes-
-related distress which has not been fully validated; 
however, it had good reliability in assessing many of 
the same diabetes-related feelings (stress, worry, fear, 
burnout) as other measures of the same construct [14]. 
Research implications
Additional longitudinal studies are needed to 
assess the impact of the events studied here on the 
psychological adjustment to having diabetes. Moving 
beyond the issues addressed in the present research, 
we need to understand what factors are associated 
with variation in the impact of these events on the 
psychological adjustment of people with diabetes, e.g., 
outcome expectations, coping strategies, etc. Does the 
patient’s response to events early in the progression 
of diabetes (e.g., acceptance of diagnoses) alter the 
trajectory of the progression? This knowledge would 
permit us to develop a more patient — centered under-
standing of the progression of diabetes. Research also 
should determine whether different complications have 
different consequences for psychological adjustment. 
Relatedly, do the benefits of treatment intensification 
in term of preventing complications outweigh any 
psychological impact of increased treatment burden? 
What factors in current treatment intensification, if 
any, contribute to psychological impact and how might 
new developments in diabetes therapies diminish nega-
tive impact? And while our primary analyses simply 
regarded diabetes-related distress and psychological 
well-being as independent outcomes, it is likely that 
they are differentially sensitive to the events studied 
(e.g., as shown for time since diagnosis of diabetes) 
and that each affects the others’ course of develop-
ment, a topic that warrants further research. Finally, 
research should examine whether the progression of 
states changes over time. 
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Clinical implications
This study suggests that state transitions in diabe-
tes (treatment intensification and occurrence of com-
plications) are associated with sustained deterioration 
in psychological adjustment. While the psychological 
impact of a complication tends to wane somewhat 
over time, it does not disappear entirely, and it is not 
clear what processes produce this (partial) remission. 
Nevertheless, the results of this study suggest that 
people with diabetes experiencing these potentially 
traumatic events should be monitored and receive 
psychological treatment and support as appropriate 
to restore quality of life [27].
Acknowledgements
Mark Peyrot’s participation in this study was sup-
ported by funding from the sponsor of the DAWN study, 
Novo Nordisk A/S, which also made the data available 
to us. The authors received no assistance in preparing 
this paper and are responsible for all data analyses and 
interpretations. We acknowledge the role of the DAWN 
International Advisory Board in guiding the study and 
their support in the dissemination of study findings. 
The preliminary data from the present study were 
partially presented at the 15th Scientific Meeting of 
the PSAD (PsychoSocial Aspects of Diabetes) Study 
Group [23].
REFERENCES
1. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunc-
tion during progression to diabetes. Diabetes. 2004; 53 Suppl 
3: S16–S21, doi: 10.2337/diabetes.53.suppl_3.s16, indexed in 
Pubmed: 15561905.
2. Alberti K, Zimmet PZ. Definition, diagnosis and classification of 
diabetes mellitus and its complications. Part 1: diagnosis and clas-
sification of diabetes mellitus. Provisional report of a WHO Con-
sultation. Diabetic Medicine. 1998; 15(7): 539–553, doi: 10.1002/
(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s.
3. Fonseca VA. Defining and characterizing the progression of type 
2 diabetes. Diabetes Care. 2009; 32 Suppl 2: S151–S156, doi: 
10.2337/dc09-S301, indexed in Pubmed: 19875543.
4. Seino Y, Nanjo K, Tajima N, et al. Committee of the Japan Diabetes 
Society on the Diagnostic Criteria of Diabetes Mellitus. Report 
of the committee on the classification and diagnostic criteria 
of diabetes mellitus. J Diabetes Investig. 2010; 1(5): 212–228, 
doi: 10.1111/j.2040-1124.2010.00074.x, indexed in Pubmed: 
24843435.
5. Gonnella JS (ed.). Disease staging: clinical and coded criteria. 
Version 5.27. Thomson Reuters, Ann Arbor, Michigan 2010.
6. Hamburg BA, Innoff GE. Coping with predictable crises of diabe-
tes. Diabetes Care. 1983; 6: 409–416.
7. Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 
2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 
2008; 31(12): 2383–2390, doi: 10.2337/dc08-0985, indexed in 
Pubmed: 19033418.
8. Palinkas LA, Barrett-Connor E, Wingard DL. Type 2 Diabetes and 
Depressive Symptoms in Older Adults: a Population-based Study. 
Diabetic Medicine. 1991; 8(6): 532–539, doi: 10.1111/j.1464-
5491.1991.tb01646.x.
9. Noh JH, Park JK, Lee HJ, et al. Depressive symptoms of type 2 
diabetics treated with insulin compared to diabetics taking oral 
anti-diabetic drugs: a Korean study. Diabetes Res Clin Pract. 2005; 
69(3): 243–248, doi: 10.1016/j.diabres.2004.10.009, indexed in 
Pubmed: 16046024.
10. Li C, Ford ES, Strine TW, et al. Prevalence of depression among 
U.S. adults with diabetes: findings from the 2006 behavioral risk 
factor surveillance system. Diabetes Care. 2008; 31(1): 105–107, 
doi: 10.2337/dc07-1154, indexed in Pubmed: 17934145.
11. Hendra TJ, Taylor CD. A randomised trial of insulin on well-being 
and carer strain in elderly type 2 diabetic subjects. J Diabetes 
Complications. 2004; 18(3): 148–154, doi: 10.1016/j.jdiaco-
mp.2003.11.001, indexed in Pubmed: 15145325.
12. Reza M, Taylor CD, Towse K, et al. Insulin improves well-being for 
selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract. 
2002; 55(3): 201–207, indexed in Pubmed: 11850096.
13. Peyrot M, Rubin RR. Levels and risks of depression and anxiety 
symptomatology among diabetic adults. Diabetes Care. 1997; 
20(4): 585–590, doi: 10.2337/diacare.20.4.585, indexed in 
Pubmed: 9096984.
14. Fisher L, Mullan JT, Skaff MM, et al. Predicting diabetes distress in 
patients with Type 2 diabetes: a longitudinal study. Diabet Med. 
2009; 26(6): 622–627, doi: 10.1111/j.1464-5491.2009.02730.x, 
indexed in Pubmed: 19538238.
15. Semenkovich K, Brown ME, Svrakic DM, et al. Depression in type 
2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 
2015; 75(6): 577–587, doi: 10.1007/s40265-015-0347-4, indexed 
in Pubmed: 25851098.
16. Perrin NE, Davies MJ, Robertson N, et al. The prevalence of 
diabetes-specific emotional distress in people with Type 2 
diabetes: a systematic review and meta-analysis. Diabet Med. 
2017; 34(11): 1508–1520, doi: 10.1111/dme.13448, indexed in 
Pubmed: 28799294.
17. De Berardis G, Pellegrini F, Franciosi M, et al. QuED (Quality of 
Care and Outcomes in Type 2 Diabetes) Study Group. Longitudi-
nal assessment of quality of life in patients with type 2 diabetes 
and self-reported erectile dysfunction. Diabetes Care. 2005; 
28(11): 2637–2643, doi: 10.2337/diacare.28.11.2637, indexed 
in Pubmed: 16249532.
18. Bernbaum M, Albert SG, Duckro PN. Psychosocial profiles in 
patients with visual impairment due to diabetic retinopathy. Dia-
betes Care. 1988; 11(7): 551–557, doi: 10.2337/diacare.11.7.551, 
indexed in Pubmed: 3203572.
19. Peyrot M, Rubin RR, Lauritzen T, et al. Patient and provider per-
ceptions of care for diabetes: results of the cross-national DAWN 
Study. Diabetologia. 2006; 49(2): 279–288, doi: 10.1007/s00125-
005-0048-8, indexed in Pubmed: 16397792.
20. Peyrot M, Rubin RR, Lauritzen T, et al. Psychosocial problems and 
barriers to improved diabetes management: results of the Cross-
National Diabetes Attitudes, Wishes and Needs (DAWN) Study. 
Diabet Med. 2005; 22(10): 1379–1385, doi: 10.1111/j.1464-
5491.2005.01644.x, indexed in Pubmed: 16176200.
21. Bonsignore M, Barkow K, Jessen F, et al. Validity of the five-item 
WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch 
Psychiatry Clin Neurosci. 2001; 251 Suppl 2: II27–II31, indexed 
in Pubmed: 11824831.
22. Topp CW, Østergaard SD, Søndergaard S, et al. The WHO-5 Well-
Being Index: a systematic review of the literature. Psychother 
Psychosom. 2015; 84(3): 167–176, doi: 10.1159/000376585, 
indexed in Pubmed: 25831962. 
23. Peyrot M. Psychological well-being and diabetes-related distress 
across stages of type 2 diabetes in the multi-national Diabetes 
Attitudes, Wishes and Needs (DAWN) Study. The 15th Scientific 
Meeting of the PSAD Study Group, PsychoSocial Aspects of Dia-
betes Study Group, Cambridge, UK, 16–18 April 2010. Abstract 
booklet. 29.
Mark Peyrot et al., Psychological well-being and diabetes-related distress in states of type 2 diabetes in the DAWN Study
175
24. Lin EHB, Rutter CM, Katon W, et al. Depression and advanced 
complications of diabetes: a prospective cohort study. Diabetes 
Care. 2010; 33(2): 264–269, doi: 10.2337/dc09-1068, indexed 
in Pubmed: 19933989.
25. Nefs G, Pop VJ, Denollet J, et al. Depressive Symptom Clusters 
Differentially Predict Cardiovascular Hospitalization in People 
With Type 2 Diabetes. Psychosomatics. 2015; 56(6): 662–673, 
doi: 10.1016/j.psym.2015.06.006, indexed in Pubmed: 26481961.
26. Novak M, Mucsi I, Rhee CM, et al. Increased Risk of Incident Chronic 
Kidney Disease, Cardiovascular Disease, and Mortality in Patients With 
Diabetes With Comorbid Depression. Diabetes Care. 2016; 39(11): 
1940–1947, doi: 10.2337/dc16-0048, indexed in Pubmed: 27311494.
27. Young-Hyman D, de Groot M, Hill-Briggs F, et al. Psychosocial Care 
for People With Diabetes: A Position Statement of the American 
Diabetes Association. Diabetes Care. 2016; 39(12): 2126–2140, 
doi: 10.2337/dc16-2053, indexed in Pubmed: 27879358.
